2014
DOI: 10.1002/uog.13375
|View full text |Cite
|
Sign up to set email alerts
|

Fetoscopic laser coagulation for twin-twin transfusion syndrome before 17 weeks' gestation: laser data, complications and neonatal outcome

Abstract: Objective To compare laser data, complications and neonatal outcome in pregnancies that undergo 'early' (≤ 17 weeks' gestation)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
30
1
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(38 citation statements)
references
References 15 publications
5
30
1
2
Order By: Relevance
“…The laser photocoagulation technique has already been described in a previous paper [19]. Amnioinfusion was always performed to facilitate access to the vascular equator.…”
Section: Methodsmentioning
confidence: 99%
“…The laser photocoagulation technique has already been described in a previous paper [19]. Amnioinfusion was always performed to facilitate access to the vascular equator.…”
Section: Methodsmentioning
confidence: 99%
“…2,5,28,29 However, this may still represent an underestimation of the true rate of early-onset TTTS, as cases of liquor discrepancy leading to intrauterine fetal death may not be classified as TTTS. Of cases treated with laser; two-thirds of fetuses survived.…”
Section: Discussionmentioning
confidence: 99%
“…1 TTTS affects 8-15% MCDA pregnancies, with 7-23% of cases requiring treatment prior to 18 weeks' gestation in large prospective studies ('earlyonset' TTTS). [2][3][4][5] The severity of TTTS is categorised typically using Quintero Stages I-V, based on standardised ultrasound findings. 6 This staging system was validated for diagnosis of TTTS from 18 weeks' gestational age (GA) onwards but is not prognostic.…”
Section: Introductionmentioning
confidence: 99%
“…There is, however, increasing evidence that laser ablation above and below these arbitrary cutoffs have comparable outcomes in survival rates and complication rates. [51][52][53][54] Data are limited on the impact of intervention for stage I TTTS. In the Eurofetus Trial, there were only 11 stage I cases, 6 laser and 5 AR cases and they were analyzed together with the stage II cases.…”
Section: Treatmentmentioning
confidence: 98%